Bio Green Med Solution, Inc.

BGMSSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1130166

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue, Net (Deprecated 2018-01-31)	—	—	—	—	—
Cost of Goods Sold (Deprecated 2018-01-31)	—	—	—	—	—
Research and Development Expense	$19.2M	$20.3M	$15.5M	$4.8M	$4.7M
Selling, General and Administrative Expense	$6.7M	$7.4M	$7.5M	$5.9M	$5.0M
Operating Expenses	$25.9M	$27.7M	—	—	—
Operating Income (Loss)	-$25.5M	-$27.7M	-$22.9M	-$10.6M	-$9.7M
Interest Expense	—	—	—	—	—

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$8.8M	$28.1M	$42.6M	$36.8M	$15.3M
Assets, Current	$7.4M	$24.4M	$40.9M	$35.5M	$14.0M
Cash and Cash Equivalents, at Carrying Value	$3.4M	$18.3M	$36.6M	$33.4M	$11.9M
Liabilities	$8.2M	$7.6M	$5.3M	$3.5M	$3.6M
Liabilities, Current	$8.2M	$7.5M	$5.3M	$2.5M	$2.4M
Accounts Payable, Current	$3.5M	$2.6M	$2.1M	$514.0K	$890.0K
Stockholders' Equity Attributable to Parent	$15.9M	$37.7M	$33.3M	$11.7M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$16.1M	-$20.8M	-$18.5M	-$7.9M	-$9.4M
Net Cash Provided by (Used in) Investing Activities	-$6.0K	-$7.0K	-$27.0K	-$96.0K	$28.0K
Net Cash Provided by (Used in) Financing Activities	$848.0K	$3.0M	$21.7M	$29.5M	$3.8M
Payments to Acquire Property, Plant, and Equipment	$6.0K	$7.0K	$27.0K	$96.0K	$10.0K
Payments for Repurchase of Equity	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)